Final Overall Survival Results from a Phase 3 Study to...

  • Main
  • 2020 / 9
  • Final Overall Survival Results from a Phase 3 Study to...
European Urology 2020 / 9

Final Overall Survival Results from a Phase 3 Study to Compare Tivozanib to Sorafenib as Third- or Fourth-line Therapy in Subjects with Metastatic Renal Cell Carcinoma

Pal, Sumanta K., Escudier, Bernard J., Atkins, Michael B., Hutson, Thomas E., Porta, Camillo, Verzoni, Elena, Needle, Michael N., Powers, Daniel, McDermott, David F., Rini, Brian I.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
European Urology
DOI:
10.1016/j.eururo.2020.08.007
Date:
September, 2020
File:
PDF, 342 KB
2020
Conversion to is in progress
Conversion to is failed